Connected Health
This week's top stories include use of the Johnson & Johnson vaccine being halted due to rare, severe reactions and the Mayo Clinic launching a platform that delivers advanced, AI-powered clinical decision support through remote monitoring.
Drs. John Sedor and Prabir Roy-Chaudhury give an update on the government-sponsored KidneyX accelerator.
When the pandemic struck, the health system re-tasked its RPM technology from CHF and COPD home care to COVID-19 home care. The results were tremendous.
Anumana will develop and market algorithms for early detection of disease. Lucem Health can collect device data and feed it into clinical workflows. Both spin-offs aim to capitalize on advances in AI and remote telemetry.
A physician expert in RPM discusses why the technology is so important to patient care and outcomes, and describes what needs to happen to capitalize on its promise.
The study found that patients using AliveCor Kardia Mobile required fewer follow-up EGCs and cardiac monitoring than their peers in the control group.
The development of PennOpen Pass, a symptom tracker and exposure alert system, offers a lesson on how challenging factors can focus the mind, enabling development of new tools that meet communities' needs.
BlueJeans Telehealth enables one-click-access to video visits between patients and providers and maps user experience to clinical workflows, according to Verizon Business – helping replicate in-person office consults.
The technology is aimed at creating a complete picture of patient health by using clinical, social and population data.
The technology could be useful in the near future when presenting proof of COVID-19 vaccinations.